Casdin Capital, LLC Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$910.4B
Holdings
29
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (29 positions)
| Stock | Value |
|---|---|
—SPARK THERAPEUTICS INC | $107.0B |
2L9BLUEPRINT MEDICINES CORP | $67.9B |
—MYOKARDIA INC | $66.8B |
SG7SAGE THERAPEUTICS INC | $63.6B |
—BLUEBIRD BIO INC | $56.2B |
NVTA1EURINVITAE CORP | $51.5B |
FATEFATE THERAPEUTICS INC | $44.8B |
—MAGENTA THERAPEUTICS INC | $43.5B |
BLFSBIOLIFE SOLUTIONS INC | $43.4B |
ALNYALNYLAM PHARMACEUTICALS INC | $41.6B |
CDXSCODEXIS INC | $41.6B |
—AUDENTES THERAPEUTICS INC | $39.4B |
SRPTSAREPTA THERAPEUTICS INC | $36.4B |
—GENMARK DIAGNOSTICS INC | $23.9B |
AGIOAGIOS PHARMACEUTICALS INC | $22.6B |
VYGRVOYAGER THERAPEUTICS INC | $21.6B |
—CONSTELLATION PHARMCETICLS I | $21.1B |
ILMNILLUMINA INC | $18.6B |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $15.9B |
2JQGRITSTONE ONCOLOGY INC | $14.9B |
EDITEDITAS MEDICINE INC | $11.7B |
GBYSANGAMO THERAPEUTICS INC | $10.3B |
FIXXEURHOMOLOGY MEDICINES INC | $9.7B |
ONCBEIGENE LTD | $9.2B |
EVHEVOLENT HEALTH INC | $6.9B |
CDNACAREDX INC | $6.3B |
ALECALECTOR INC | $6.2B |
GILDGILEAD SCIENCES INC | $5.2B |
DNLIDENALI THERAPEUTICS INC | $2.3B |